JP2006525365A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525365A5
JP2006525365A5 JP2006514244A JP2006514244A JP2006525365A5 JP 2006525365 A5 JP2006525365 A5 JP 2006525365A5 JP 2006514244 A JP2006514244 A JP 2006514244A JP 2006514244 A JP2006514244 A JP 2006514244A JP 2006525365 A5 JP2006525365 A5 JP 2006525365A5
Authority
JP
Japan
Prior art keywords
alkyl
allyl
independently
groups
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006514244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525365A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/013701 external-priority patent/WO2004099170A2/en
Publication of JP2006525365A publication Critical patent/JP2006525365A/ja
Publication of JP2006525365A5 publication Critical patent/JP2006525365A5/ja
Pending legal-status Critical Current

Links

JP2006514244A 2003-04-30 2004-04-30 フェニル置換カルボン酸 Pending JP2006525365A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46686803P 2003-04-30 2003-04-30
PCT/US2004/013701 WO2004099170A2 (en) 2003-04-30 2004-04-30 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b

Publications (2)

Publication Number Publication Date
JP2006525365A JP2006525365A (ja) 2006-11-09
JP2006525365A5 true JP2006525365A5 (cg-RX-API-DMAC7.html) 2007-06-21

Family

ID=33434989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006514244A Pending JP2006525365A (ja) 2003-04-30 2004-04-30 フェニル置換カルボン酸

Country Status (13)

Country Link
US (1) US7524878B2 (cg-RX-API-DMAC7.html)
EP (1) EP1620422A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006525365A (cg-RX-API-DMAC7.html)
KR (1) KR20060006954A (cg-RX-API-DMAC7.html)
CN (1) CN1812978A (cg-RX-API-DMAC7.html)
AU (1) AU2004236248A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0409916A (cg-RX-API-DMAC7.html)
CA (1) CA2524235A1 (cg-RX-API-DMAC7.html)
EA (1) EA200501713A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA05011536A (cg-RX-API-DMAC7.html)
NO (1) NO20055129L (cg-RX-API-DMAC7.html)
WO (1) WO2004099170A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200509635B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006525364A (ja) 2003-04-30 2006-11-09 ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー 置換アミノカルボン酸
KR20060080197A (ko) 2003-09-17 2006-07-07 오노 야꾸힝 고교 가부시키가이샤 카르복실산 화합물 및 이들을 유효 성분으로서 함유하는의약 조성물
ES2352085T3 (es) 2004-05-05 2011-02-15 High Point Pharmaceuticals, Llc Nuevos compuestos, su preparación y uso.
WO2005105736A1 (en) 2004-05-05 2005-11-10 Novo Nordisk A/S Novel compounds, their preparation and use
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EA200700243A1 (ru) 2004-07-14 2007-08-31 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Способы лечения гепатита с
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
EP1781289A1 (en) 2004-07-22 2007-05-09 PTC Therapeutics, Inc. Thienopyridines for treating hepatitis c
EP1844043A2 (en) * 2004-11-18 2007-10-17 The Institutes for Pharmaceutical Discovery, LLC Heterocycle substituted carboxylic acids for the treatment of diabetes
EP1836182A2 (en) * 2004-11-18 2007-09-26 The Institutes for Pharmaceutical Discovery, LLC Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
JP2008520693A (ja) 2004-11-18 2008-06-19 ジ インスチチュート フォー ファーマシューティカル ディスカバリー、エルエルシー プロテインチロシンホスファターゼ阻害剤としての置換アミノ酸
DE102004060542A1 (de) * 2004-12-16 2006-07-06 Sanofi-Aventis Deutschland Gmbh Hydroxybiphenyl-Carbonsäuren und Derivate, Verfahren zu deren Herstellung und deren Verwendung
WO2006117657A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Triazolone derivatives as anti-inflammatory agents
ES2372617T3 (es) 2005-06-30 2012-01-24 High Point Pharmaceuticals, Llc Ácidos fenoxiacéticos como activadores de ppar-delta.
CN101296914B (zh) 2005-08-26 2012-07-18 盐野义制药株式会社 具有ppar激动活性的衍生物
EA201101085A1 (ru) 2005-12-22 2012-05-30 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Феноксиуксусные кислоты в качестве активаторов ppar дельта
US7989461B2 (en) 2005-12-23 2011-08-02 Amgen Inc. Substituted quinazolinamine compounds for the treatment of cancer
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
WO2008033934A1 (en) * 2006-09-13 2008-03-20 The Institutes For Pharmaceutical Discovery, Llc Substituted heteroaryl carboxylic acid derivatives as ptb-1b inhibitors
WO2008033931A1 (en) * 2006-09-13 2008-03-20 The Institutes For Pharmaceutical Discovery, Llc Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib
JP2010531358A (ja) 2007-06-27 2010-09-24 メルク・シャープ・エンド・ドーム・コーポレイション ヒストン脱アセチル化酵素阻害剤としてのピリジル及びピリミジニル誘導体
WO2009002495A1 (en) 2007-06-27 2008-12-31 Merck & Co., Inc. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
JP2011506445A (ja) * 2007-12-13 2011-03-03 アムジエン・インコーポレーテツド γ−セクレターゼ調節剤
UA103319C2 (en) 2008-05-06 2013-10-10 Глаксосмитклайн Ллк Thiazole- and oxazole-benzene sulfonamide compounds
ES2512727T3 (es) 2009-09-29 2014-10-24 Glaxo Group Limited Nuevos compuestos
DE102009046115A1 (de) 2009-10-28 2011-09-08 Bayer Schering Pharma Aktiengesellschaft Substituierte 3-Phenylpropansäuren und ihre Verwendung
JP5814031B2 (ja) * 2010-07-30 2015-11-17 ユー・ディー・シー アイルランド リミテッド 有機電界発光素子、及びジベンゾチオフェン構造又はジベンゾフラン構造を有する有機電界発光素子用材料
CN102382037B (zh) * 2010-09-03 2016-01-20 中国医学科学院药物研究所 苯丙酸类化合物及其制法和药物用途
US9107983B2 (en) 2010-10-27 2015-08-18 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising statins
US8877221B2 (en) 2010-10-27 2014-11-04 Warsaw Orthopedic, Inc. Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
JP5989660B2 (ja) 2010-12-07 2016-09-07 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 置換1−ベンジルシクロアルキルカルボン酸およびその使用
AU2011346670B2 (en) 2010-12-23 2015-05-07 Pfizer Inc. Glucagon receptor modulators
PH12013501557A1 (en) 2011-02-08 2019-06-03 Pfizer Glucagon receptor modulator
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
US9308190B2 (en) 2011-06-06 2016-04-12 Warsaw Orthopedic, Inc. Methods and compositions to enhance bone growth comprising a statin
RU2013157388A (ru) 2011-07-22 2015-08-27 Пфайзер Инк. Хинолинильные модуляторы глюкагонового рецептора
DE102012208530A1 (de) 2012-05-22 2013-11-28 Bayer Pharma AG Substituierte Piperidinoacetamide und ihre Verwendung
PT3013796T (pt) * 2013-06-27 2020-03-26 Lg Chemical Ltd Derivados biarílicos como agonistas de gpr120
JO3425B1 (ar) 2013-07-15 2019-10-20 Novartis Ag مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
US20170114049A1 (en) 2014-04-03 2017-04-27 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
WO2015150363A1 (de) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung
CN106458938A (zh) 2014-04-03 2017-02-22 拜耳制药股份公司 手性2,5‑二取代的环戊烷甲酸衍生物及其用途
US11427600B2 (en) 2014-06-27 2022-08-30 Nogra Pharma Limited Aryl receptor modulators and methods of making and using the same
CU24413B1 (es) 2014-12-18 2019-05-03 Bayer Pharma AG Ácidos piridil-cicloalquil-carboxílicos sustituidos útiles para el tratamiento de enfermedades asociadas al dolor, y para el tratamiento o profilaxis de los síndromes del dolor, de la endometriosis, la adenomiosis y el cáncer
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
CN116693514A (zh) * 2022-03-01 2023-09-05 上海璎黎药业有限公司 一类芳香环取代的甲氧基衍生物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243678A (en) * 1977-12-30 1981-01-06 Byk Gulden Lomberg Chemische Fabrik Gmbh Acylhydrocarbylaminoalkanoic acids, compositions and uses
JPS59141540A (ja) * 1983-02-01 1984-08-14 Chisso Corp 三環カルボン酸エステル誘導体
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
DE69821294T2 (de) * 1997-07-25 2004-11-18 Eastman Kodak Co. Lichtempfindliche Silberhalogenidemulsionsschicht mit verstärkter photographischer Empfindlichkeit
DE19907904A1 (de) * 1999-02-24 2000-08-31 Clariant Gmbh Verfahren zur Herstellung von [1,1':4',1"]-Terphenylverbindungen
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
AU2001239550A1 (en) 2000-03-23 2001-10-03 Takeda Chemical Industries Ltd. Furoisoquinoline derivatives, process for producing the same and use thereof
JP4105446B2 (ja) * 2002-02-20 2008-06-25 富士フイルム株式会社 重合性化合物およびそのマトリックスを用いた光学素子

Similar Documents

Publication Publication Date Title
JP2007510619A5 (cg-RX-API-DMAC7.html)
JP2009535462A5 (cg-RX-API-DMAC7.html)
JP2009541403A5 (cg-RX-API-DMAC7.html)
JP2006526031A5 (cg-RX-API-DMAC7.html)
JP2007500753A5 (cg-RX-API-DMAC7.html)
JP2005053931A5 (cg-RX-API-DMAC7.html)
EP1852184A4 (en) CERAMIC WAVE STRUCTURE
JP2007508359A5 (cg-RX-API-DMAC7.html)
PL2308942T3 (pl) Zastosowanie kompozycji zawierającej trans-1,3,3,3-tetrafluoropropen (trans-HFO- 1234ze) jako czynnik chłodniczy
JP2007511546A5 (cg-RX-API-DMAC7.html)
JP2009523760A5 (cg-RX-API-DMAC7.html)
JP2009545527A5 (cg-RX-API-DMAC7.html)
JP2008501000A5 (cg-RX-API-DMAC7.html)
JP2010520214A5 (cg-RX-API-DMAC7.html)
MX2011007864A (es) Isosteros para realzar la transcripcion y su uso en terapia.
EP1773849A4 (en) FUNCTIONALIZED SILICON CONNECTIONS
JP2010534246A5 (cg-RX-API-DMAC7.html)
JP2006522692A5 (cg-RX-API-DMAC7.html)
JP2012511558A5 (cg-RX-API-DMAC7.html)
JP2008540542A5 (cg-RX-API-DMAC7.html)
AU2003238671A1 (en) Novel crystalline forms of s-omeprazole magnesium
HRP20080552A9 (en) Benzimidazole derivative and use thereof
JP2013189393A5 (cg-RX-API-DMAC7.html)
JP2005029789A5 (cg-RX-API-DMAC7.html)
JP2011079866A5 (cg-RX-API-DMAC7.html)